Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases. (Q55475232)

12 July 2018

title

Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases. (English)

1 reference

12 July 2018

1 reference

1 reference

1 reference

Korshunov A

1

1 reference

12 July 2018

Golanov A

series ordinal

2

1 reference

12 July 2018

Timirgaz V

series ordinal

3

1 reference

12 July 2018

publication date

1 August 2000

1 reference

12 July 2018

Journal of the Neurological Sciences

published in

1 reference

12 July 2018

volume

177

1 reference

12 July 2018

issue

1

1 reference

12 July 2018

page(s)

72-82

1 reference

12 July 2018

Intracranial ependymomas: a review.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

The molecular biology of ependymomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Supratentorial lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Intracranial ependymoma in children: analysis of prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

The clinical and prognostic relevance of grading in intracranial ependymomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Intracranial ependymomas: analysis of prognostic factors in a population-based series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Intracranial ependymoma long term outcome, patterns of failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Ependymoma: results, prognostic factors and treatment recommendations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Infratentorial ependymomas in childhood: prognostic factors and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Intracranial ependymomas of childhood: long-term outcome and prognostic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Ependymomas: a clinicopathologic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Lack of histopathological correlation of malignant ependymomas with postoperative survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Prognostic factors in childhood intracranial ependymomas: the role of age and tumor location.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Histologic prognostic factors in ependymoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Disseminated ependymomas of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Ependymomas: MIB-1 proliferation index and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Prognostic value of tumor-associated antigens immunoreactivity and apoptosis in medulloblastomas. An analysis of 73 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Relative Risk Trees for Censored Survival Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Tenascin distribution in human brain tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Differential expression of tenascin-C and tenascin-X in human astrocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Expression and distribution of vascular endothelial growth factor protein in human brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Epidermal growth factor receptors on ependymomas and other brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

The challenge of p53 as prognostic and predictive factor in gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Molecular analysis of genetic changes in ependymomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Infrequency of p53 gene mutations in ependymomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Molecular cytogenetic studies of pediatric ependymomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Molecular genetic analysis of non-astrocytic gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

p27/kip1 expression in oligodendrogliomas and its possible prognostic role.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

p27Kip1 expression by contact inhibition as a prognostic index of human glioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

p27/kip1 expression in human astrocytic gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Apoptosis in neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Biological evaluation of biopsies from adult cerebral astrocytomas: cell-growth/cell-suicide ratios and their relationship to patient survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

Treatment of intracranial ependymomas of children: review of a 15-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900347-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(00)00347-6

1 reference

12 July 2018

PubMed ID

10967185

1 reference

12 July 2018